Tatiana Witjas1, Romain Carron2, Paul Krack2, Alexandre Eusebio2, Marianne Vaugoyeau2, Marwan Hariz2, Jean Philippe Azulay2, Jean Régis2. 1. From the Department of Neurology and Movement Disorders (T.W., A.E., J.P.A.) and Department of Functional and Stereotactic Neurosurgery and Radiosurgery (R.C., J.R.), Assistance Publique-Hôpitaux de Marseille, Aix-Marseille Université, Timone University Hospital; Institut de Neurosciences de la Timone (T.W., A.E., J.P.A.), UMR 7289, CNRS Aix-Marseille Université, Marseille, France; Université Grenoble Alpes (P.K.), GIN INSERM U318 and CHU de Grenoble, Movement Disorder Unit, Grenoble, France; CNRS-Aix-Marseille Université (M.V.), Laboratory of Cognitive Neurosciences, FR 3 C, Marseille, France; Unit of Functional Neurosurgery (M.H.), UCL Institute of Neurology, Queen Square, London, UK; Department of Clinical Neuroscience (M.H.), Umeå University, Sweden; and INSERM (R.C., J.R.), UMR 1106, Aix-Marseille Université, Marseille, France. tatiana.witjas@ap-hm.fr. 2. From the Department of Neurology and Movement Disorders (T.W., A.E., J.P.A.) and Department of Functional and Stereotactic Neurosurgery and Radiosurgery (R.C., J.R.), Assistance Publique-Hôpitaux de Marseille, Aix-Marseille Université, Timone University Hospital; Institut de Neurosciences de la Timone (T.W., A.E., J.P.A.), UMR 7289, CNRS Aix-Marseille Université, Marseille, France; Université Grenoble Alpes (P.K.), GIN INSERM U318 and CHU de Grenoble, Movement Disorder Unit, Grenoble, France; CNRS-Aix-Marseille Université (M.V.), Laboratory of Cognitive Neurosciences, FR 3 C, Marseille, France; Unit of Functional Neurosurgery (M.H.), UCL Institute of Neurology, Queen Square, London, UK; Department of Clinical Neuroscience (M.H.), Umeå University, Sweden; and INSERM (R.C., J.R.), UMR 1106, Aix-Marseille Université, Marseille, France.
Abstract
OBJECTIVE: To evaluate the safety and efficacy of unilateral Gamma Knife thalamotomy (GKT) for treatment of severe tremor with a prospective blinded assessment. METHODS: Fifty patients (mean age: 74.5 years; 32 men) with severe refractory tremor (36 essential, 14 parkinsonian) were treated with unilateral GKT. Targeting of the ventral intermediate nucleus (Vim) was achieved with Leksell Gamma Knife with a single shot through a 4-mm collimator helmet. The prescription dose was 130 Gy. Neurologic and neuropsychological assessments including a single-blinded video assessment of the tremor severity performed by a movement disorders neurologist from another center were performed before and 12 months after treatment. MRI follow-up occurred at 3, 6, and 12 months. RESULTS: The upper limb tremor score improved by 54.2% on the blinded assessment (p < 0.0001). All tremor components (rest, postural, and intention) were improved. Activities of daily living were improved by 72.2%. Cognitive functions remained unchanged. Following GKT, the median delay of improvement was 5.3 months (range 1-12 months). The only side effect was a transient hemiparesis associated with excessive edema around the thalamotomy in one patient. CONCLUSION: This blinded prospective assessment demonstrates that unilateral GKT is a safe and efficient procedure for severe medically refractory tremor. Side effects were rare and transient in this study. CLASSIFICATION OF EVIDENCE: This study provides Class IV evidence that for patients with severe refractory tremor, GKT is well tolerated and effective in reducing tremor impairment.
OBJECTIVE: To evaluate the safety and efficacy of unilateral Gamma Knife thalamotomy (GKT) for treatment of severe tremor with a prospective blinded assessment. METHODS: Fifty patients (mean age: 74.5 years; 32 men) with severe refractory tremor (36 essential, 14 parkinsonian) were treated with unilateral GKT. Targeting of the ventral intermediate nucleus (Vim) was achieved with Leksell Gamma Knife with a single shot through a 4-mm collimator helmet. The prescription dose was 130 Gy. Neurologic and neuropsychological assessments including a single-blinded video assessment of the tremor severity performed by a movement disorders neurologist from another center were performed before and 12 months after treatment. MRI follow-up occurred at 3, 6, and 12 months. RESULTS: The upper limb tremor score improved by 54.2% on the blinded assessment (p < 0.0001). All tremor components (rest, postural, and intention) were improved. Activities of daily living were improved by 72.2%. Cognitive functions remained unchanged. Following GKT, the median delay of improvement was 5.3 months (range 1-12 months). The only side effect was a transient hemiparesis associated with excessive edema around the thalamotomy in one patient. CONCLUSION: This blinded prospective assessment demonstrates that unilateral GKT is a safe and efficient procedure for severe medically refractory tremor. Side effects were rare and transient in this study. CLASSIFICATION OF EVIDENCE: This study provides Class IV evidence that for patients with severe refractory tremor, GKT is well tolerated and effective in reducing tremor impairment.
Authors: Richard A Popple; Xingen Wu; Ivan A Brezovich; James M Markert; Barton L Guthrie; Evan M Thomas; Markus Bredel; John B Fiveash Journal: Adv Radiat Oncol Date: 2018-03-02
Authors: Elena Najdenovska; Constantin Tuleasca; João Jorge; Philippe Maeder; José P Marques; Timo Roine; Daniel Gallichan; Jean-Philippe Thiran; Marc Levivier; Meritxell Bach Cuadra Journal: Sci Rep Date: 2019-02-04 Impact factor: 4.379
Authors: Robert Francis Dallapiazza; Darrin J Lee; Philippe De Vloo; Anton Fomenko; Clement Hamani; Mojgan Hodaie; Suneil K Kalia; Alfonso Fasano; Andres M Lozano Journal: J Neurol Neurosurg Psychiatry Date: 2018-10-18 Impact factor: 10.154